UnitedHealth options volatility doubles ahead of earnings

UnitedHealth Group reports its quarterly earnings on October 13, with options prices currently reflecting implied volatility at twice the level of realized volatility. This pricing structure indicates that the cost of insuring the underlying stock is elevated, a condition that sets up opportunities for short premium strategies. According to Cboe LiveVol data, current options prices imply a 6.5% move in the stock following the report, which represents the second highest implied move in nearly two years.

The valuation gap exists because the market is pricing in 40% volatility for a stock that has been realizing 20%. Analysts note that this elevated implied volatility captures the specific risk of the upcoming earnings release, a factor likely driven by the stock's history of sharp declines in recent quarters. In January, UnitedHealth shares fell almost 20% following an earnings report, and a similar sharp decline occurred in April 2025. As of the latest data, UnitedHealth stock trades approximately 12% to 13% below the midpoint of its two-year high and low range.

Operationally, the company faces mixed enrollment trends that influence its earnings per share growth targets. Management has set a target for EPS growth between 13% and 16%, a figure described as achievable despite ongoing headwinds from rising healthcare costs. While enrollment in the ACA marketplace appears poised to decline, a trend that acts as a revenue headwind in a segment that had previously driven growth, other segments show expansion. Commercial fee-based enrollment grew approximately 2.9% year over year between 2024 and 2025. Total Medicare enrollment grew 4.5% over the same period. Given that the U.S. workforce grew roughly 1.4% during this timeframe, the growth in the commercial segment suggests UnitedHealth is gaining market share.

The company’s financial metrics indicate a conservative pricing stance. UnitedHealth trades at 17 times forward earnings. Free cash flow stands at 5.7% of enterprise value and 6.5% of market capitalization, figures that suggest the stock is not priced for an immediate recovery. The stock has been essentially flat over the last five years, having traded lower in five of the last eight earnings reports. UnitedHealth serves 52 million customers worldwide, with 90% of those customers located in the United States. By its own statistics, the company covers approximately 12% to 13.5% of the U.S. population.

Traders are utilizing specific options structures to capitalize on the volatility spread. One strategy involves selling November premium to reduce the cost of a longer-dated January call by more than half. A specific trade structure involves selling a November strangle to finance the purchase of a January 2027 call option with a $400 strike price. The January $400 call costs $18.20. Selling the November call and put legs generates $10.60 in premium income. This results in a net debit of approximately $7.60, cutting the effective cost of the January call by roughly 58%. If UnitedHealth finishes November within the short strangle range, both short legs expire worthless, leaving the January call held for $7.60 with a breakeven of $407.60 at expiration.